Skip to main content
. 2021 Jul 20;5:69. doi: 10.1038/s41698-021-00206-y

Fig. 5. Comparisons of NTRK fusion-positive tumour types in entrectinib adult clinical studies versus FoundationCORE database.

Fig. 5

CRC colorectal cancer, MASC mammary analogue secretory carcinoma, NSCLC non-small cell lung cancer, NTRK neurotrophic tyrosine receptor kinase.